Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
RAPT logo

RAPT

NSD
RAPT Therapeutics Inc.
Professional, Scientific, and Technical ServicesResearch and Development in Biotechnology
Watchlists:
Last updated: Monday 14th July 2025
8.46
-0.16 (-1.86%)
Prev Close:8.62
Open:8.57
Bid:8.31
Ask:9.58
52 Week Range
5.66
30.60
Volume:109,109
Mkt Cap:133 M
Price Target
$9.73
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

RAPT - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Invalid date
Depreciation And Amortization1 M1 M1000000.01000000.01 M-1 M
General And Administrative Expense29 M26 M20 M16 M13 M9 M
Gross Profit Margin (profit Margin After CGS)2 M4 M5 M
Misc Other Special Charges6 M10 M2 M5000.01 M
Net Income (loss)-130 M-117 M-84 M-69 M-53 M-43 M
Net Income Common Stockholders-130 M-117 M-84 M-69 M-53 M-43 M
Net Income Continuous Operations-130 M-117 M-84 M-69 M-53 M-43 M
Net Non Operating Interest Income Expense1 M
Normalized Income-129 M-66 M-55 M
Operating Income-136 M-127 M-86 M-69 M-53 M-44 M
Operating Income Before Depreciation (EBITDA)-129 M-116 M-83 M-68 M-52 M-41 M
Operating Expense136 M127 M87 M73 M58 M-44 M
Other Gand A29 M26 M20 M16 M13 M9 M
Other Operating Expenses-905000.0-1 M-759000.0-1 M-544000.0-466000.0
Rent And Landing Fees9 M
Research Expense107 M101 M67 M57 M45 M35 M
Salaries And Wages20 M17 M-2 M
Total Income Available For Interest Expense (EBIT)-130 M-117 M-84 M-69 M-53 M-42 M
Total Revenues2 M4 M5 M
Total Expenses136 M127 M87 M73 M58 M-44 M
Total Revenue2 M4 M5 M
Avgshs41 M5 M33 M3 M3 M543300.0
Avgshsdt41 M5 M33 M3 M543440.0
Basiceps-3.19-24.4-2.58-20.24-17.52
Basicepscont-3.19-24.4-2.58-20.24-17.52
Depamor1 M1 M1000000.01000000.01 M-1 M
Dileps-3.19-24.4-2.58-20.24-17.5279.12
Dilepscont-3.19-24.4-2.58
Intinc1 M
Netincdisc-130 M-117 M-84 M-69 M-53 M-43 M
Othincexp-6 M-10 M-2 M-5000.0-1 M
Pretaxinc-130 M-117 M-84 M-69 M-52 M-42 M
Resdev107 M101 M67 M57 M45 M35 M
Sga29 M26 M20 M16 M13 M9 M
Shsout132 M4 M34 M4 M3 M3 M
Taxprov990000.0660000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader